Arovella Therapeutics (ASX: ALA)

Last close As at 20/12/2024

0.03

0.00 (0.00%)

Market capitalisation

AUD26m

Arovella Therapeutics is a biotechnology company focused on developing therapies to treat cancer and conditions that affect the central nervous system.

Latest Insights

View More

Healthcare | Flash note

Arovella Therapeutics — Strategic refocus on iNKT platform

Healthcare | Flash note

Arovella Therapeutics — Positive collaboration with ALA-101

Healthcare | Update

Arovella Therapeutics — Progressing on all fronts

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free